ELAVL1 and follicular thyroid adenoma: HuR expression has been noted in the majority of tissues from benign and malignant thyroid lesions, that is, hyperplastic nodules, Hashimoto thyroiditis, follicular adenomas, FTCs, PTCs, and ATCs, with a moderate to high immunoreactivity in almost half of those [97, 98].